The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants - Pellicer, A; Greisen, G; Benders, M (Neonatology, 2013)
et al.